share_log

Matinas BioPharma | 8-K: Matinas BioPharma Reports First Quarter 2022 Financial Results and Operational Highlights

SEC ·  May 12, 2022 18:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more